Prime Day

Como cliente Amazon Prime obtén 3 meses de Audible gratis

Diseño de la portada del título Parkinson's and the B1 Therapy

Parkinson's and the B1 Therapy

Muestra

Suscríbete a la prueba gratuita para poder disfrutar de este libro a un precio exclusivo para suscriptores

Pagar 4,89 € con prueba
Después de los 30 días, 9,99 €/mes. Cancela tu siguiente plan mensual cuando quieras.
Disfruta de más de 90.000 títulos de forma ilimitada.
Escucha cuando y donde quieras, incluso sin conexión
Sin compromiso. Cancela tu siguiente plan mensual cuando quieras.

Parkinson's and the B1 Therapy

De: Daphne Bryan PhD
Narrado por: Anna Crowe
Pagar 4,89 € con prueba

Después de los 30 días, 9,99 €/mes. Cancela cuando quieras.

Compra ahora por 6,99 €

Compra ahora por 6,99 €

In 2011, the Italian neurologist Dr Antonio Costantini began treating his Parkinson’s patients with high doses of B1. As a result, their symptoms improved by up to 70 percent with no obvious progression in the disease over the five years he worked with them. Yet there is still a lack of awareness about this valuable therapy amongst doctors and Parkinson’s nurses.

This book is intended for people with Parkinson’s and their health professionals. It presents theories and hypotheses to explain the substantial effect thiamine has on the brain, discusses the available research which has studied the effect of high doses of B1 on Parkinson’s patients, and details the protocol, as we currently understand it, for patients and doctors who wish to use the therapy.

Parkinson’s is a degenerative disease and consequently there is a sense of urgency for neurologists, doctors, and Parkinson’s nurses to acquaint themselves with this therapy. This treatment is immediately available, relatively inexpensive and safe, and for many of us has improved our lives significantly.

Sadly, in 2020 Dr. Costantini died from Covid-19. However, his colleagues, wishing to continue his work, have designed a rigorous research project to understand more about the effect of high doses of thiamine on the Parkinson’s brain. This in-depth research is needed before the therapy will be adopted by mainstream medicine. The research team have, however, been unable to procure funding to start this important study.

©2022 Daphne Bryan PhD (P)2023 Daphne Bryan PhD
Enfermedad física y trastornos
adbl_web_anon_alc_button_suppression_c
No hay reseñas aún